| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 119 |
| 1 | METHOTREXATE SODIUM | 119 |
| 2 | METHOTREXATE | 102 |
| 3 | BELANTAMAB MAFODOTIN | 99 |
| 4 | LATANOPROST | 99 |
| 5 | ADALIMUMAB | 78 |
| 6 | PREDNISONE | 72 |
| 7 | DEXAMETHASONE 1.5 MG | 70 |
| 8 | PREDNISOLONE ACETATE | 67 |
| 9 | ASPIRIN | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BELANTAMAB MAFODOTIN | 99 | 0.0319 |
| 1 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 7 | 0.0191 |
| 2 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 15 | 0.0137 |
| 3 | TROPICAMIDE | 21 | 0.0129 |
| 4 | BESIFLOXACIN | 12 | 0.0124 |
| 5 | NEPAFENAC | 35 | 0.0110 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | 6 | 0.0108 |
| 7 | GATIFLOXACIN | 17 | 0.0095 |
| 8 | BALANCED SALT SOLUTION | 12 | 0.0093 |
| 9 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 9 | 0.0079 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 302 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 192 |
| 2 | Prostaglandin Analog [EPC] | 148 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 118 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 105 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 70 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 66 |
| 7 | Proton Pump Inhibitor [EPC] | 64 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 60 |
| 9 | Vitamin C [EPC] | 59 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cyclooxygenase Inhibitor [EPC] | 1 | 0.0122 |
| 1 | Polyene Antimicrobial [EPC] | 3 | 0.0073 |
| 2 | Adrenocorticotropic Hormone [EPC] | 5 | 0.0056 |
| 3 | Antileishmanial [EPC] | 2 | 0.0052 |
| 4 | Quinolone Antimicrobial [EPC] | 43 | 0.0044 |
| 5 | Plasma Volume Expander [EPC] | 13 | 0.0042 |
| 6 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 2 | 0.0024 |
| 7 | alpha-1 Adrenergic Agonist [EPC] | 10 | 0.0023 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 30 | 0.0022 |
| 9 | Carbonic Anhydrase Inhibitor [EPC] | 44 | 0.0022 |